West Reports Third-Quarter 2025 Results

Proprietary Products SegmentNet sales of $647.5 million grew by 7.7% and increased 5.1% on an organic basis. Contract-Manufactured Products SegmentNet sales of $157.1 million increased by 8.0% and rose 4.9% on an organic basis. Segment performance was driven by an increase in sales of self-injection devices for obesity and diabetes, which was partially offset by a decrease in sales of healthcare diagnostic devices. Contract-Manufactured Products accounted for 20% of total company net sales in the quarter. A ...